Navigation Links
Aetna Foundation funding Boston University obesity research
Date:2/28/2011

The Aetna Foundation today announced significant funding in support of five research studies designed to deepen understanding of the root causes of the nation's well-documented obesity epidemic and drive viable solutions to the core problems. More than $1 million in funding will be granted in support of separate studies at New York University School of Medicine, Boston University School of Medicine (BUSM), the University of Michigan, the University of Pennsylvania and Yale University's CARE program.

Julie Palmer, Sc.D., from Boston University's School of Medicine (BUSM) Slone Epidemiology Center, will serve as Principal Investigator on the two-year $233,000 grant, which will focus on obesity in African- American women.

"While on its surface, the nation's obesity epidemic appears simple we consume too many calories and don't get enough exercise the issue is far more complex and the data available on what drives these unhealthy behaviors, particularly in urban, poor or minority communities, is scant," said Anne C. Beal, MD, MPH, president of the Aetna Foundation. "To help build the knowledge base and support development of effective policies that will foster healthier communities and a healthier nation, we are supporting these key research projects. These studies will consider issues such as the availability of broad food choices and the pricing of food, as well as the impact these factors have on individual food choices. The studies also will look at the role of our neighborhoods and the impact of what is or isn't in the 'built environment' where we live, work and play-- on population health and weight loss."

Details on the BUSM grant are as follows:

$233,000 to Boston University's School of Medicine Slone Epidemiology Center for a two-year study of factors that influence obesity among African-American women, including both individual and neighborhood-level factors, and the identification of the most effective small cha
'/>"/>

Contact: Jenny Eriksen
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
2. Entertainment Software Association Foundation awards grant to FAS for immune attack
3. National Science Foundation grants Clemson professors award to develop nanoprobes
4. Dunn Foundation gives Rice $3M for collaborative research grants
5. National Science Foundation grant expands UMCES oyster research
6. UT Southwestern researcher awarded Gates Foundation grant for novel vaccine development
7. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
8. Parkinsons Disease Foundation announces award of $150,000
9. Meyskens honored with AACR-Prevent Cancer Foundation award
10. The MDS foundation supports vidazas recommendation for European approval
11. Boost from McGill, Gates Foundation helps Africans control pharma research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Census Bureau, Latinos are the largest minority group in ... Approximately one-third of Latinos are obese and are 1.2 ... Whites. , NYU College of Nursing student researcher ... identify the factors that contribute to this problem by ... on food patterns in Latina women recently published in ...
(Date:7/31/2014)... follow-up study (HPV-023; NCT00518336) shows the sustained ... papilloma virus (HPV) vaccine Cervarix. Women vaccinated ... for more than nine years, and vaccine ... This is the longest follow-up report for ... for the full paper. , ...
(Date:7/31/2014)... from Spain, France, and the U.S. has discovered ... oldest definitive member of the tribe Omaliini that ... and description were made possible through the use ... which allows the detailed study of otherwise invisible ... described in the journal Annals of the ...
Breaking Biology News(10 mins):NYU research looks to combat US Latina immigrant obesity 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3
... Research has awarded a five-year, $7.5 million grant to a ... project is to study birds, insects and bats in order ... fly in unpredictable conditions such as zooming through dense ... to fly in open spaces or in very controlled environments," ...
... Spanish . U.S. Department of Agriculture ... first time that several species of Aspergillus niger ... and peanuts as endophytes. The researchers also showed that, ... a molecular procedure they developed, USDA Agricultural Research Service ...
... The National Institute of General Medical Sciences (NIGMS) has ... Yeshiva University a five-year, $30 million grant to study ... proteins. "Determining the structures of proteins is the ... processes as well as in disease pathways," says principal ...
Cached Biology News:UW leading $7.5 million study of animal flight and aerial vehicles 2Black aspergilli species responsible for infecting corn identified 2Einstein receives $30 million to study protein form and function 2Einstein receives $30 million to study protein form and function 3Einstein receives $30 million to study protein form and function 4
(Date:7/31/2014)... -- Chemists at Indiana University Bloomington have described ... fashion, a development with potential value for the ... transistors and photovoltaic cells. , Their paper, "Anion-Induced ... Solids and 2D Self-Assembled Crystals," has been published ... of the Royal Society of Chemistry. It is ...
(Date:7/31/2014)... Rogne Bioscience, a privately-held biotechnology company based ... has acquired a licence to anti-inflammatory peptides from Isis ... anti-inflammatory activity of the peptides was discovered by Professor ... Sir William Dunn School of Pathology. ... million in seed financing, is developing a first-in-class, topical ...
(Date:7/31/2014)... July 31, 2014 According to ... "Electrodes for Medical Devices Market (Diagnostic Electrodes - ECG, ... - TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - ... 2013 - 2019," the global electrodes market for medical ... and is estimated to reach a market worth USD ...
(Date:7/31/2014)... July 31, 2014 Senomyx , ... company using proprietary taste science technologies to discover, ... food, beverage, and ingredient supply industries, today reported ... Company ended the second quarter with $33.6 million ... "During the past quarter Senomyx achieved another ...
Breaking Biology Technology:Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 2Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 4Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 5Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 14SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 15SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 16
... Seamless Performance Between GeneChip Scanner 3000 and the ... , ... Instrument System is the most advanced microarray analysis platform available and ... processes have enabled Affymetrix to produce expression probe arrays with greater consistency ...
... , Gang Li a , Savvas Damaskinos a ... a Biomedical Photometrics Inc., A12-550 Parkside ... b Dept. of Biology, Wilfrid Laurier University, 75 University Ave. ... , ABSTRACT , ...
... , L.Pereira, 1 M.Woodruff, 1 P.Deland, 2 ... , ... CA,USA , 3 Astra Zeneca R&D, Charnwood,UK , ... performance of various diode array detectors in the analysis of trace related substances of a ...
Cached Biology Technology:The New Affymetrix GeneChip Scanner 3000 2The New Affymetrix GeneChip Scanner 3000 3The New Affymetrix GeneChip Scanner 3000 4The New Affymetrix GeneChip Scanner 3000 5The New Affymetrix GeneChip Scanner 3000 6The New Affymetrix GeneChip Scanner 3000 7The New Affymetrix GeneChip Scanner 3000 8The New Affymetrix GeneChip Scanner 3000 9The New Affymetrix GeneChip Scanner 3000 10The New Affymetrix GeneChip Scanner 3000 11The New Affymetrix GeneChip Scanner 3000 12The New Affymetrix GeneChip Scanner 3000 13The New Affymetrix GeneChip Scanner 3000 14The New Affymetrix GeneChip Scanner 3000 15A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 2A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 3A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 4A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 5A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 6A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 7A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 8A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 9A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 10A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 11A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 12A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 13A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 14A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 15A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 16A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 17A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 18A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 19A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 20A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 21A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 22
... The Light Diagnostics Universal Amplicon ... for use in the qualitative ... generated by in vitro ... use only; not to be ...
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
... complete ready-to-use reagents for the isolation of ... formulated for the isolation of genomic DNA ... formulated for the isolation of genomic DNA ... Reagents can be used for restriction endonuclease ...
Concentration: 1mg/ml. Antigen: Propidium Iodide ...
Biology Products: